(E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide
TL;DR: (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide (CAS 847243-08-7) is a chemical compound with molecular formula C25H18N4O2S and molecular weight 438.12 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
(2E)-N-benzyl-2-cyano-2-[(5E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylidene)-1,3-thiazolidin-2-ylidene]acetamide
Also Known As: (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide, (2E)-N-benzyl-2-cyano-2-[(5E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylidene)-1,3-thiazolidin-2-ylidene]acetamide
| Molecular Formula | C25H18N4O2S |
|---|---|
| Molecular Weight | 438.12 g/mol |
| LogP | 2.11348 |
| Topological Polar Surface Area | 87.78 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Exact Mass | 438.11505 |
| Heavy Atoms | 32 |
| Complexity | 1451.8634 |
Chemical Identifiers
| CAS Number | 847243-08-7 |
|---|---|
| SMILES | C1=CC=C(C=C1)CNC(=O)/C(=C/2\N(C(=O)/C(=C\C3=CN=CC=C3)/S2)C4=CC=CC=C4)/C#N |
Product Overview
(E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide (CAS 847243-08-7), with molecular formula C25H18N4O2S and molecular weight 438.12 g/mol. IUPAC: (2E)-N-benzyl-2-cyano-2-[(5E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylidene)-1,3-thiazolidin-2-ylidene]acetamide.
Chemical Property Profile of (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide
Property Insights of (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide
The XLogP value of 2.11348 suggests moderate lipophilicity, balancing water solubility and membrane permeability for (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide. The TPSA of 87.78 Ų falls within the moderate polarity range, balancing permeability and solubility for (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide. Following Lipinski's Rule of Five, (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide has 1 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide?
The CAS number of (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide is 847243-08-7.
What is the molecular formula of (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide?
The molecular formula of (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide is C25H18N4O2S.
What is the molecular weight of (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide?
The molecular weight of (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide is 438.12 g/mol.
Where can I buy (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide?
You can request a quote for (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide?
Yes, KEHONG BIO provides custom synthesis services for (E)-N-benzyl-2-cyano-2-((E)-4-oxo-3-phenyl-5-(pyridin-3-ylmethylene)thiazolidin-2-ylidene)acetamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.